EU Panel Recommends Approving Alexza's Adasuve

On Friday, Alexza Pharmaceuticals (NASDAQ: ALXA  ) and Grupo Ferrer International, S.A., announced that Europe's Committee for Medicinal Products for Human Use (CHMP) has issued a "positive opinion" recommending that their Adasuve anti-agitation drug be approved for sale in the European Union.

Specifically, CHMP recommended that Adasuve be authorized in the EU for the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder, provided the drug is "administered only in a hospital setting under the supervision of a health care professional" and that drugs be kept at hand to deal with possible severe respiratory side effects. CHMP's ruling was based on clinical trial results that showed "statistically significant reductions in agitation from baseline compared to placebo."

CHMP's recommendation is not binding, and will now go to the European Commission, which will render a binding decision, probably in the first quarter of next year.

Alexza estimates that as many as 8 million adults in the EU suffer from schizophrenia or bipolar disorder; agitation is a common symptom for those people.

Shares of Alexza are up nearly 10% on the news, at $5.75 per share.

 

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2154951, ~/Articles/ArticleHandler.aspx, 11/29/2014 3:46:10 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement